Get ready to energize your life?
Top Offers Only Today
Support your health and step-up your mental focus
post in: Beauty Date:12 Nov 2017, 15:18 views:3070
Vassallo graduated as an MD from the University of Malta in 1992.
Following completion of medical school and house officer training, he pursued residency training in Internal Medicine at the Mayo Clinic from 1995 to 1998, and subsequently trained as a clinician-investigator in the specialty of pulmonary and critical care medicine at the Mayo Clinic in Rochester. From 2001 to 2003 he was a Mayo Clinic Foundation Scholar in human translational immunology (Mentor; Lieping Chen, MD, PhD).
In 2003 he joined the consulting staff at the Mayo Clinic and currently practices as a pulmonary specialist with clinical efforts committed to outpatient pulmonary consultative care and inpatient pulmonary hospital care. Vassallos research and clinical interests focus on cigarette smoke mediated lung diseases.
Specifically, his research is focused on understanding mechanisms by which cigarette smoking and dysregulated immunity promote lung diseases like copd, asthma and interstitial lung disease.
His research program has been supported by the Mayo Foundation, the National Institutes of Health, the Flight Attendant Medical benefits Research Institute, the American Lung Association, the Parker B Francis Foundation, the Histiocytosis Association of America, and the Rheumatology Research Foundation.
Abstract: Asthma Management An update, asthma, an inflammatory disorder of the airways, is highly prevalent worldwide and causes considerable morbidity. This presentation will review recent advances in the pathophysiology, diagnostic assessment and management of adult patients with asthma.
Novel insights regarding the role of aberrant mucosal immunology (including the roles of novel Th2 polarizing factors and the Th17 lungs pathway) will be discussed. Potential pathophysiologic mechanisms in severe asthma, and the development of airway remodeling in chronic and more severe asthma will be reviewed. Exhaled nitric oxide testing is a novel tool used in the diagnosis and follow-up of established asthma, and is a useful clinical adjunct to clinical disease assessment tools in monitoring response to treatment.
Current recommendations for therapy will be discussed, and recent data regarding the utility of anti-cholinergic therapy, the use of anti-Immunoglobulin-E therapy, biologic agents that inhibit eosinophil functions, and anti-Interleukin-13 therapy will be reviewed. The role of bronchial thermoplasty in the management of severe asthma will also be reviewed.lung
Finally, updates in the management of acute asthma in hospitalized patients will be discussed, and the roles of non-invasive ventilation, heliox, magnesium sulphate and other acute management strategies will be reviewed. Novel treatments in Pulmonary Hypertension.